REAL-TIME DETECTION OF BIOMOLECULAR STRUCTURAL CHANGES WITH HIGH THROUGHPUT

Biodesy has developed a novel optical platform to rapidly measure structural changes of biological molecules in real time, based on a phenomenon called second-harmonic generation (SHG). By changing conformation, proteins and other biological molecules modulate function, interact with different molecules, and participate in multiple molecular pathways. Therefore, characterizing these changes provides significant insights into how different biomolecules function and respond to different protein partners, native ligands, drug candidates, etc. Biodesy’s mass-independent, SHG-based detection of structural changes enables high-throughput, robust assays to directly monitor binding-induced structural changes in a wide array of biomolecular drug targets, from RNA to large protein complexes.

News

Biodesy Announces Corporate Name Change to BlueLight Therapeutics

May 27, 2020

Biodesy Announces New CEO and $20 Million Series C Financing to Accelerate Expansion into Biotherapeutics Discovery and Development Market

September 10, 2018

Events

Drug Discovery Chemistry 2019

April 9-April 11, 2019 San Diego Convention Center, San Diego, CA

Presenting at Fragment-based Lead Discovery Conference (FBLD) 2018

October 7-October 10, 2018 San Diego, USA